Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma : An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

van Meerbeeck, Jan P.; Gaafar, Rabab; Manegold, Christian; Van Klaveren, Rob. J.; Van Marck, Eric A.; Vincent, Mark; Legrand, Catherine; Bottomley, Andrew; Debruyne, Channa; Giaccone, Giuseppe

doi:10.1200/JCO.20005.14.589

Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma : An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

van Meerbeeck, Jan P.

;

Gaafar, Rabab

;

Manegold, Christian

;

Van Klaveren, Rob. J.

;

Giaccone, Giuseppe

;et.al.

(2005) Journal of Clinical Oncology — Vol. 23, n° 28, p. 6881-6889 (2005)

Files

No attached file found for this publication.

Details

Authors

van Meerbeeck, Jan P.University Hospital Ghent
Author
Gaafar, RababNational Cancer Center
Author
Manegold, ChristianUMC Mannheim
Author
Van Klaveren, Rob. J.Erasmus MC
Author
Legrand, CatherineUCLouvain
Author
Giaccone, GiuseppeFree University Medical Center
Author

Affiliations

UCLouvainEUEN/STAT - Institut de statistique

Citations

APA
Chicago
FWB

van Meerbeeck, J. P., Gaafar, R., Manegold, C., Van Klaveren, Rob. J., Van Marck, E. A., Vincent, M., Legrand, C., Bottomley, A., Debruyne, C., & Giaccone, G. (2005). Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma : An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. Journal of Clinical Oncology, 23(28), 6881-6889. https://doi.org/10.1200/JCO.20005.14.589 (Original work published 2005)